Adverse Outcomes in Pulmonary Tuberculosis patients on Retreatment Regimen: Evaluation of Pharmacokinetic Estimates as Risk Indicators

Anant Mohan, Anuj Bhatnagar, Tarang Gupta, Sunita Kanswal, Ujjalkumar Das, Thirumurthy Velpandian, Randeep Guleria, Urvashi B. Singh
doi: https://doi.org/10.1101/2021.08.11.21261879

Article Information

doi 
https://doi.org/10.1101/2021.08.11.21261879
History 
  • August 11, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Anant Mohan1,
  2. Anuj Bhatnagar2,
  3. Tarang Gupta1,
  4. Sunita Kanswal1,
  5. Ujjalkumar Das1,
  6. Thirumurthy Velpandian1,
  7. Randeep Guleria1 and
  8. Urvashi B. Singh1,*
  1. 1All India Institute of Medical Sciences, New Delhi, India
  2. 2Rajan Babu Institute of Pulmonary Medicine and Tuberculosis and Hospital, New Delhi, India
  1. ↵*Correspondence to: drurvashi{at}gmail.com
Back to top
Posted August 11, 2021.
Download PDF
Data/Code
Email
Adverse Outcomes in Pulmonary Tuberculosis patients on Retreatment Regimen: Evaluation of Pharmacokinetic Estimates as Risk Indicators
Anant Mohan, Anuj Bhatnagar, Tarang Gupta, Sunita Kanswal, Ujjalkumar Das, Thirumurthy Velpandian, Randeep Guleria, Urvashi B. Singh
medRxiv 2021.08.11.21261879; doi: https://doi.org/10.1101/2021.08.11.21261879
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area